Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nanotechnology ; 21(22): 225301, 2010 Jun 04.
Artigo em Inglês | MEDLINE | ID: mdl-20453283

RESUMO

We have fabricated Nb nanogap electrodes using a combination of molecular lithography and electron beam lithography. Au nano-particles with anchor molecules were placed in the gap, the width of which could be controlled on a molecular scale (approximately 2 nm). Three different anchor molecules which connect the Au nano-particles and the electrodes were tested to investigate their contact resistance, and a local gate was fabricated underneath the Au nano-particles. The electrical transport measurements at liquid helium temperatures indicated single electron transistor (SET) characteristics with a charging energy of about approximately 5 meV, and a clear indication of the effect of superconducting electrodes was not observed, possibly due to the large tunnel resistance.

2.
Eur J Pharmacol ; 236(2): 337-8, 1993 May 19.
Artigo em Inglês | MEDLINE | ID: mdl-8319760

RESUMO

The appearance of nephrotic syndromes such as proteinuria, hypoalbuminemia, hypercholesterolemia and increase in blood nitrogen urea, induced in rats by injection of puromycin aminonucleoside was markedly inhibited by oral administration of Dup 753 (losartan), a novel angiotensin II receptor antagonist, at a dose of 1 or 2 mg/kg per day. The results suggest a possible involvement of the renin-angiotensin system in the development of puromycin aminonucleoside-induced nephrosis.


Assuntos
Angiotensina II/antagonistas & inibidores , Compostos de Bifenilo/uso terapêutico , Imidazóis/uso terapêutico , Nefrose/prevenção & controle , Puromicina Aminonucleosídeo/antagonistas & inibidores , Tetrazóis/uso terapêutico , Animais , Nitrogênio da Ureia Sanguínea , Colesterol/sangue , Losartan , Masculino , Nefrose/induzido quimicamente , Puromicina Aminonucleosídeo/toxicidade , Ratos , Ratos Sprague-Dawley , Sistema Renina-Angiotensina/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...